-
1دورية أكاديمية
المؤلفون: Luo, Jia, Makhnin, Alex, Tobi, Yosef, Ahn, Linda, Hayes, Sara A., Iqbal, Afsheen, Ng, Kenneth, Arcila, Maria E., Riely, Gregory J., Kris, Mark G., Yu, Helena A.
المصدر: JCO Precision Oncology; 5/10/2021, Vol. 5, p55-64, 10p
مصطلحات موضوعية: PROTEIN-tyrosine kinase inhibitors, EPIDERMAL growth factor receptors, OVERALL survival, SURVIVAL rate, ERLOTINIB, SPEECH apraxia
-
2دورية أكاديمية
المؤلفون: Arbour, Kathryn C.1, Kris, Mark G.1,2, Riely, Gregory J.1,2, Ni, Ai3, Beal, Kathryn4, Daras, Mariza5, Hayes, Sara A.6, Young, Robert J.6, Rodriguez, Christopher R.1, Ahn, Linda1, Pao, William7, Yu, Helena A.1,2 yuh@mskcc.org
المصدر: Cancer (0008543X). Jan2018, Vol. 124 Issue 1, p105-109. 5p.
مصطلحات موضوعية: *ERLOTINIB, *DISEASE progression, *EPIDERMAL growth factor receptors, *LUNG cancer, *BRAIN metastasis, *ADENOCARCINOMA, *ANTHROPOMETRY, *BRAIN tumors, *EPIDERMAL growth factor, *LUNG tumors, *GENETIC mutation, *PROGNOSIS, *RADIOTHERAPY, *RESEARCH funding, *TREATMENT effectiveness, *PROTEIN kinase inhibitors
-
3دورية أكاديمية
المؤلفون: Naidoo, Jarushka, Sima, Camelia S., Rodriguez, Katherine, Busby, Natalie, Nafa, Khedoudja, Ladanyi, Marc, Riely, Gregory J., Kris, Mark G., Arcila, Maria E., Yu, Helena A.
المصدر: Cancer (0008543X); Sep2015, Vol. 121 Issue 18, p3212-3220, 10p
مصطلحات موضوعية: LUNG cancer treatment, CANCER treatment, ADENOCARCINOMA, ERLOTINIB, EPIDERMAL growth factor receptors, EXONS (Genetics), PROTEIN-tyrosine kinase inhibitors, DRUG resistance in cancer cells, THERAPEUTICS
-
4دورية أكاديمية
-
5دورية أكاديمية
المؤلفون: Liu, Vincent, White, Dorothy A., Zakowski, Maureen F., Tranis, William, Kris, Mark G., Ginsberg, Michelle S., Miller, Vincent A., Azzoli, Christopher C.
المصدر: CHEST; Sep2007, Vol. 132 Issue 3, p1042-1044, 3p, 2 Black and White Photographs
مصطلحات موضوعية: EPIDERMAL growth factor, PULMONARY fibrosis, INTERSTITIAL lung diseases, PULMONARY toxicology, PROTEIN-tyrosine kinases
-
6دورية أكاديمية
المؤلفون: Jänne, Pasi A1,2 pasi_janne@dfci.harvard.edu, Ou, Sai-Hong I3, Kim, Dong-Wan4, Oxnard, Geoffrey R1, Martins, Renato5, Kris, Mark G6, Dunphy, Frank7, Nishio, Makoto8, O'Connell, Joseph9, Paweletz, Cloud2, Taylor, Ian10, Zhang, Hui11, Goldberg, Zelanna12, Mok, Tony13
المصدر: Lancet Oncology. Dec2014, Vol. 15 Issue 13, p1433-1441. 9p.
مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *NON-small-cell lung carcinoma, *ENZYME inhibitors, *GEFITINIB, *ERLOTINIB, *CANCER treatment, *CLINICAL trials, *THERAPEUTICS